HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serum resistin in persistent allergic rhinitis: preliminary data in adults.

AbstractBACKGROUND:
Adipokines may exert pro-inflammatory activities in allergic rhinitis. Resistin is a new adipokine. Only one study reported that resistin may be involved in allergic rhinitis. However, that study was conducted in children. Therefore, the present study aimed at confirming these findings also in adult patients with persistent allergic rhinitis (PER).
METHODS:
The study included 85 PER patients subjects 25 (11 males, mean age 35.4 years) with mild symptoms and 60 (27 males, mean age 36.8 years) with moderate-severe ones. All subjects were consecutively evaluated. A skin prick test and blood sampling for assessing serum resistin levels were performed in all subjects.
RESULTS:
Patients with moderate-severe symptoms had higher resistin levels than mild ones (p=0.02).
CONCLUSION:
This study provides the preliminary evidence that resistin serum levels depend on symptom severity also in adults with PER.
AuthorsGiorgio Ciprandi, Mara De Amici, Maria Angela Tosca, Gianluigi Marseglia
JournalInternational immunopharmacology (Int Immunopharmacol) Vol. 10 Issue 3 Pg. 371-2 (Mar 2010) ISSN: 1878-1705 [Electronic] Netherlands
PMID20093199 (Publication Type: Journal Article)
CopyrightCopyright 2010 Elsevier B.V. All rights reserved.
Chemical References
  • Adipokines
  • Resistin
Topics
  • Adipokines (blood)
  • Adult
  • Female
  • Humans
  • Immunoassay
  • Male
  • Resistin (blood)
  • Rhinitis, Allergic, Perennial (blood)
  • Skin Tests

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: